TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of change of Trail Making Test B-A time (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in MRI morphological criteria (brain atrophy by voxel-based morphometry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurotoxicity secondary to cancer therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in TWPI Due to Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: renal function (estimated glomerular filtration rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: quality of life of children with haemolytic uraemic syndrome and their parents
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: neuropsychological sequelae of children with haemolytic uraemic syndrome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of osteoclast precursor (CD14+) cells in the peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of osteoclasts generated in vitro
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of bone resorption in vitro
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of clinical symptoms of IBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients With All-Cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Patients With Nephrotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Anastomotic ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post-operative drainage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study participant recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of flare-up or exacerbation of Extra Articular Manifestations in Uveitis
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of flare-up or exacerbation of Extra Articular Manifestations in Psoriasis
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of flare-up or exacerbation of Extra Articular Manifestations in Inflammatory Bowel Disease
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of flare-up or exacerbation of Extra Articular Manifestations in Enthesitis of the Heel: Achilles Tendon and Plantar Fascia
Endpoint domain: Adverse events/effects
Primary endpoint: BADDS Total Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With Proven/Probable/Possible Invasive Fungal Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Bench Press Repetitions to Fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bench Press Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric Mid-thigh pull (IMTP) Peak Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric Mid-thigh pull (IMTP) Rate of Force Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Environment and Policy Assessment and Observation (EPAO) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: variation of TREF scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in cognitive functions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of glucose values in predefined ranges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in SPPB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of composite z cognitive score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Interleukin 6 (IL-6) plasmatic concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endotoxin plasmatic mass concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient satisfaction of implant-supported prosthesis
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Score for high impact questions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean of the Average Nicotine Binding %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Social Behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cytokine levels (HMGB-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of Responders at Month 6 Based on DYS Pain Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of Responders at Month 6 Based on NMPP Pain Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of Sexual Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prevalence of Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patency Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in expression of phoenixin and humanin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of P. falciparum gametocyte carriers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Normalization of Glucose Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Characterisation of infected leucocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine gene expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RNA gene expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of ADHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fistulization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Health-related quality of life (CFQ-R scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: relative change in the VerifyNow Aspirin test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Performance Quality Rating Scale (PQRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Spectral amplitude of the alpha band (8-14 Hz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Levels of dihomo-gamma linolic acid in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptoms of atopic dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized rate of moderate, severe COPD exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain intensity with the Numeric Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief by pain medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The current health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hamilton Depression Rating Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants With Normal or Abnormal Activated Partial Thromboplastin Time (aPTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent Change in Platelet Count From Pre-dose Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Incidents of Epistaxis
Endpoint domain: Adverse events/effects
Primary endpoint: PreS specific IgG antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Catheter dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: contralateral upper limb tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of Major Adverse Clinical Events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Brief Visuospatial Memory Test Revised (BVMT-R)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Dropouts due to serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cannabis abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Depression status
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximum selected dose (MSD) or maximum tolerated dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients with liver cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Number of patients with hepatic encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients with ascites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients with hepatocellular carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Satisfaction with the notification process
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite rate of All Death, Myocardial Infarction (MI) and Target Vessel Revascularization (TVR)
Endpoint domain: Mortality/survival
Primary endpoint: Psychomotor Vigilance Test-Brief (PVT-B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slow-wave Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Driver gene mutation frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival prognosis
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of pulmonary venous stenosis after repairing TAPVC with sutureless technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early mortality (<30 days)
Endpoint domain: Mortality/survival
Primary endpoint: QTc interval using Fridericia's correction method (QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amount of intact replication-competent HIV-1 sequences in CD4 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Specificity and sensitivity of identification of PD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: qRT-PCR results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRCT chest findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montgomery-Ashberg Depression Scale (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Global Impression Severity Scale (CGI-S)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of functional connectivity of default mode network (DMN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of smoke-free status
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Fit of the crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Prescribed Calories From Energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Prescribed Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in airway remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: International restless legs scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the skin towards sunlight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hepatic sinusoidal injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Correlation of glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to Maximum Observed Plasma Concentration of Risdiplam (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve from Time 0 to Last Measurable Concentration Time Point (AUC0-last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermatology Life Quality Index 0/1 Response
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: periapical index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RV pressure estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: amelioration of subjective sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: amelioration of daytime anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: amelioration of dream anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Toxicity of Infusing HER2-specific T Cells
Endpoint domain: Adverse events/effects
Primary endpoint: Medication helpfulness rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression Free Survival time (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: National Institutes of Health Stroke Scale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bedtime Consistency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: clinical and radiographic observations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Clinical complete response rate (cCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of all cause death, MI, or any revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Area under the plasma concentration-time curve from zero to infinity (AUC(0-∞)) for GNS and Granisetron IV Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) for GNS and Granisetron IV Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from zero to last quantifiable concentration (AUC(0-t)) for GNS and Granisetron IV Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAV vaccination rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C Protein Reactive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: blood inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of visceral fat area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of testicular cancer development
Endpoint domain: Mortality/survival
Primary endpoint: Immune-related Adverse Events (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients Who Achieve Greater Than 50% Donor T-cell Chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Wound Care Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trajectory of Mean Wound Care Session Pain Within Sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trajectory of Mean Wound Care Session Pain Across Sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance of TI-RADS scores with surgical pathology reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With New Adverse Event (AE) of Grade >= 3
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Recovery From Grade 2 or 3 irAE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with Eckhart score ≥ 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contraception Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients converting to mastectomy based on MRI findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients having mastectomy as the final surgical procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to TIMI-defined first major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Css,max (Maximum steady state concentration) of Finasteride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCtau (Area under the plasma concentration versus time curve) of Finasteride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of testosterone and DHT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of recordings correlating to concussion diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Average Blood Glucose (BG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Time With a Low Plasma Glucose Reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in complicated grief symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in psychological trauma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Response Rate to Dabrafenib/Trametinib Combination Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Adverse Events to Dabrafenib and/or Trametinib
Endpoint domain: Adverse events/effects
Primary endpoint: Stage of pelvic floor prolapse as defined by POP-Q score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications (SAE, AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Days Platelets Count of < 100K/μL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean weight gain (g/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Truncal vein occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Transcranial Doppler microembolic signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of cases
Endpoint domain: Mortality/survival
Primary endpoint: Percent Change of Estrone (E1), Estradiol (E2), and Estrone Sulphate (E1S) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cumulative Incidence of COVID-19 Infection
Endpoint domain: Mortality/survival
Primary endpoint: Confirmed Complete Wound Closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Self-esteem level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bone Mineral Density/Content (BMD/BMC) at lumbar spine and femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Umbilical trocar-site hernia formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pelvic floor-related quality of life symptoms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of chikungunya virus in synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Appropriate ICD Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Slow VT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in EORTC QOL-C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Planning Behavior Score at 1-month
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Disability of the Arm, Shoulder and Hand (DASH) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning